---
title: "Improving Resilience and Equity in Breast Cancer Screening: Lessons from COVID-19 and Beyond"
linktext: Agenda
slug: /reports/2020/4/2
---
<div class="full-report-container">
<div class="left-nav-container">
<left-navigation root="/reports/2020/4"></left-navigation>
</div>
<div class="report-container">


**November 16, 2020**

[Day 1 Recording](https://nci.rev.vbrick.com/#/videos/f801d69d-4ad5-45cd-8cc5-8eaf4a0ea3eb)

<hr />

<table class="agenda-table">
<tbody>
<tr><td>

**1:00-1:10**
</td><td>

**Agenda Review and Administrative Statements**

Administrative remarks, facilitator introduces agenda and process

</td></tr>
<tr><td>

**1:10 – 2:00**
</td><td>

**PCP Working Group Introduction and Presentation**

PCP introduction, introduce the working team and present work to date on the landscape of opportunities, barriers, and possible solutions
</td></tr>
<tr><td>

**2:00 – 3:00**
</td><td>

**Breast Cancer Screening Improvement Opportunities Session 1: Genetic Testing Expansion and Risk-Based Screening**

Opportunities to improve screening, associated barriers, and possible solutions

- Reflect on opportunities and barriers
- Discuss and contribute ideas on ways to address the most significant barriers
</td></tr>
<tr><td>

**3:00 – 3:15**
</td><td>

Break

</td></tr>
<tr><td>

**3:15 – 4:15**
</td><td>

**Breast Cancer Screening Improvement Opportunities Session 2: Work to Eliminate Disparities in Screening**

Opportunities to improve screening, associated barriers, and possible solutions
</td></tr>
<tr><td>

**4:15 – 4:35**
</td><td>

**Working Group Review of Input and Final Comments**

Review of the day’s stakeholder input and reactions to day’s work
</td></tr>
<tr><td>

**4:35 – 5:00**
</td><td>

**Response to Public Questions and Comments**



</td></tr></tbody></table>

<hr />


**November 18, 2020**

[Day 2 Recording](https://nci.rev.vbrick.com/#/videos/d0bb6306-d615-494e-9a9f-3943b539f5e1)

<hr />

<table class="agenda-table">
<tbody>
<tr><td>

**1:00-1:15**

</td><td>

**Agenda Review and Administrative Statements**

Administrative remarks, facilitator introduces agenda and process, reflections from day 1

</td></tr>
<tr><td>

**1:15 – 2:00**

</td><td>

**Breast Cancer Screening Improvement Opportunities Session 3: Alignment of Multiple Screening Guidelines**

Opportunities to improve screening, associated barriers, and possible solutions
</td></tr>
<tr><td>

2:00 – 2:45

</td><td>

**Breast Cancer Screening Improvement Opportunities Session 4: Perception**

Opportunities to improve screening, associated barriers, and possible solutions
</td></tr>
<tr><td>

**2:45 – 3:00**
</td><td>

Break

</td></tr>
<tr><td>

**3:00 – 4:30**

</td><td>

**Cross-Cutting Theme Review**

Review of the barriers falling into each cross-cutting theme, identification of any missing barriers
- Review of barriers associated to each cross-cutting theme
- Identification of any additional barriers
- Identification of the most significant barriers
</td></tr>
<tr><td>

**4:30 – 4:40**

</td><td>

**Panel Final Comments**

Brief review of input and panel discussion of next steps
</td></tr>
<tr><td>

**4:40 – 5:00**

</td><td>

**Response to Public Questions and Comments**

</td></tr></tbody></table>

</div>
</div>
